English

Thorne HealthTech, Inc.

EDGAR

THRN Quarterly report (10-Q) · filed 2023-08-09

9 filing records in this dataset, filed from 2021-07-16 to 2023-08-09. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

72.7 million USD

2023 Q2 · USD

Exact inputs and evidence

Revenue: 72714600 USD Source

Operating margin

9.11%

2023 Q2 · %

Exact inputs and evidence

Operating Income: 6622606 USD Source
Revenue: 72714600 USD Source

Operating cash flow

15 million USD

2023 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 9285985 USD Source
Operating Cash Flow: -5725866 USD Source

Free cash flow

7.14 million USD

2023 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: 9285985 USD Source
Operating Cash Flow: -5725866 USD Source
Capital Expenditure: 21048631 USD Source
Capital Expenditure: 13173073 USD Source

Cash and cash equivalents: 17.1 million USD 2023-06-30 Source
Exact value

17093556 USD
Long-term debt including current maturities: 13.2 million USD 2022-12-31 Source
Exact value

13169559 USD
Shares outstanding: 53.9 million shares 2023-06-30 Source
Exact value

53920020 shares

Reported share-count change

2.25% · 1.19 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

52733269 shares · 2022-06-30· Source
53920020 shares · 2023-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

256 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Revenue: 58419270 USD · 2022-07-01 – 2022-09-30 Source
Revenue: 228731362 USD · 2022-01-01 – 2022-12-31 Source
Revenue: 169155294 USD · 2022-01-01 – 2022-09-30 Source
Revenue: 65237779 USD · 2023-01-01 – 2023-03-31 Source
Revenue: 72714600 USD · 2023-04-01 – 2023-06-30 Source

Net income

20.3 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Net income: 3738616 USD · 2022-07-01 – 2022-09-30 Source
Net income: 15674040 USD · 2022-01-01 – 2022-12-31 Source
Net income: 3126970 USD · 2022-01-01 – 2022-09-30 Source
Net income: -402164 USD · 2023-01-01 – 2023-03-31 Source
Net income: 4445819 USD · 2023-04-01 – 2023-06-30 Source

Operating cash flow

21.5 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Operating cash flow: -8801208 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -7007889 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: 5221904 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -8801208 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -5725866 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: 9285985 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -5725866 USD · 2023-01-01 – 2023-03-31 Source

Capital expenditure

35.9 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Capital expenditure: 5233668 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 2226073 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 17112171 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 5233668 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 13173073 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 21048631 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 13173073 USD · 2023-01-01 – 2023-03-31 Source

Free cash flow

-14.4 million USD

2022-07-01 – 2023-06-30

Exact inputs and evidence

Operating cash flow: -8801208 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -7007889 USD · 2022-01-01 – 2022-06-30 Source
Operating cash flow: 5221904 USD · 2022-01-01 – 2022-12-31 Source
Operating cash flow: -8801208 USD · 2022-01-01 – 2022-09-30 Source
Operating cash flow: -5725866 USD · 2023-01-01 – 2023-03-31 Source
Operating cash flow: 9285985 USD · 2023-01-01 – 2023-06-30 Source
Operating cash flow: -5725866 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 5233668 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 2226073 USD · 2022-01-01 – 2022-06-30 Source
Capital expenditure: 17112171 USD · 2022-01-01 – 2022-12-31 Source
Capital expenditure: 5233668 USD · 2022-01-01 – 2022-09-30 Source
Capital expenditure: 13173073 USD · 2023-01-01 – 2023-03-31 Source
Capital expenditure: 21048631 USD · 2023-01-01 – 2023-06-30 Source
Capital expenditure: 13173073 USD · 2023-01-01 – 2023-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2023-08-09.

Financial data available through: 2022-12-31.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2022-12-31
Operating income: 3 of 11 periods available· newest 2022-12-31
Net income: 3 of 11 periods available· newest 2022-12-31
Operating cash flow: 3 of 11 periods available· newest 2022-12-31
Capital expenditure: 3 of 11 periods available· newest 2022-12-31
Total assets: 3 of 11 periods available· newest 2022-12-31
Total liabilities: 3 of 11 periods available· newest 2022-12-31
Current assets: 3 of 11 periods available· newest 2022-12-31
Current liabilities: 3 of 11 periods available· newest 2022-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2022-12-31
Long-term debt including current maturities: 3 of 11 periods available· newest 2022-12-31
Shares outstanding: 3 of 11 periods available· newest 2022-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+24.1%

Prior period

USD 184.3 million

2021-01-01 – 2021-12-31
Current period

USD 228.73 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

228731362 − 184301485 = 44429877 USD

184301485 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
228731362 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Thorne HealthTech, Inc. · 2022-12-31 Thorne HealthTech, Inc. (edgar:1844280) Year-over-year change in Revenue: 44429877 USD Concept: fundies:Revenue Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 228731362 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#3280206 Filing: 000095017023011358 Input fundies:Revenue: 184301485 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#3284533 Filing: 000095017023011358
The citation records this snapshot. The page link may show a newer release later.
Net income
+116.1%

Prior period

USD 7.25 million

2021-01-01 – 2021-12-31
Current period

USD 15.67 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

15674040 − 7253423 = 8420617 USD

7253423 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
15674040 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Thorne HealthTech, Inc. · 2022-12-31 Thorne HealthTech, Inc. (edgar:1844280) Year-over-year change in Net income: 8420617 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 15674040 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#5198043 Filing: 000095017023011358 Input fundies:NetIncome: 7253423 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#5200017 Filing: 000095017023011358
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-42.5%

Prior period

USD 9.08 million

2021-01-01 – 2021-12-31
Current period

USD 5.22 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

5221904 − 9084286 = -3862382 USD

9084286 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
5221904 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Thorne HealthTech, Inc. · 2022-12-31 Thorne HealthTech, Inc. (edgar:1844280) Year-over-year change in Operating cash flow: -3862382 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 5221904 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2841657 Filing: 000095017023011358 Input fundies:OperatingCashFlow: 9084286 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2843707 Filing: 000095017023011358
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+296.9%

Prior period

USD 4.31 million

2021-01-01 – 2021-12-31
Current period

USD 17.11 million

2022-01-01 – 2022-12-31

Exact inputs and evidence

17112171 − 4311015 = 12801156 USD

4311015 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source
17112171 USD · 2022-01-01 – 2022-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Thorne HealthTech, Inc. · 2022-12-31 Thorne HealthTech, Inc. (edgar:1844280) Year-over-year change in Capital expenditure: 12801156 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 17112171 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2849426 Filing: 000095017023011358 Input fundies:CapitalExpenditure: 4311015 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2851613 Filing: 000095017023011358
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2022 2022-01-01 – 2022-12-31

Revenue USD 228.73 million 100% of revenue
Cost of revenue USD 113.8 million 50% of revenue
Operating expenses USD 82.99 million 36% of revenue
Other operating costs Derived USD 26.47 million 12% of revenue
Operating income USD 5.48 million 2.4% of revenue
Tax, interest and other Derived −USD 10.19 million −4.5% of revenue
Net income USD 15.67 million 6.9% of revenue

Cash

Operating cash flow USD 5.22 million 2.3% of revenue
Capital expenditure USD 17.11 million 7.5% of revenue
Free cash flow Derived −USD 11.89 million −5.2% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Net loss: net income was −2.4% of revenue.
2021 95%
2022 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	138454924	137440157 Derived	1014767	4372513 Derived	-3357746	15913413 Derived	Source 2020-01-01 – 2020-12-31: 138454924 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: 1014767 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -3357746 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: 17107055 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 1193642 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	184301485	174549335 Derived	9752150	2498727 Derived	7253423	4773271 Derived	Source 2021-01-01 – 2021-12-31: 184301485 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: 9752150 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: 7253423 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: 9084286 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 4311015 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	228731362	223250092 Derived	5481270	-10192770 Derived	15674040	-11890267 Derived	Source 2022-01-01 – 2022-12-31: 228731362 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: 5481270 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: 15674040 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: 5221904 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 17112171 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 228.7M 2022

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	138454924	Revenue: 138454924 Open source
20212021-12-31	Revenue	184301485	Revenue: 184301485 Open source
20222022-12-31	Revenue	228731362	Revenue: 228731362 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

24.1% 2022

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 138454924 Open source
20212021-12-31	Year over year	33.1%	Revenue: 184301485 Open source Revenue: 138454924 Open source
20222022-12-31	Year over year	24.1%	Revenue: 228731362 Open source Revenue: 184301485 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 2.4% 2022

Net margin 6.9% 2022

Free cash flow margin -5.2% 2022

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	0.7%	Operating Income: 1014767 Open source Revenue: 138454924 Open source
20212021-12-31	Operating margin	5.3%	Operating Income: 9752150 Open source Revenue: 184301485 Open source
20222022-12-31	Operating margin	2.4%	Operating Income: 5481270 Open source Revenue: 228731362 Open source
20202020-12-31	Net margin	-2.4%	Net Income: -3357746 Open source Revenue: 138454924 Open source
20212021-12-31	Net margin	3.9%	Net Income: 7253423 Open source Revenue: 184301485 Open source
20222022-12-31	Net margin	6.9%	Net Income: 15674040 Open source Revenue: 228731362 Open source
20202020-12-31	Free cash flow margin	11.5%	Revenue: 138454924 Open source Operating Cash Flow: 17107055 Open source Capital Expenditure: 1193642 Open source
20212021-12-31	Free cash flow margin	2.6%	Revenue: 184301485 Open source Operating Cash Flow: 9084286 Open source Capital Expenditure: 4311015 Open source
20222022-12-31	Free cash flow margin	-5.2%	Revenue: 228731362 Open source Operating Cash Flow: 5221904 Open source Capital Expenditure: 17112171 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 5.2M 2022

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	17107055	Operating Cash Flow: 17107055 Open source
20212021-12-31	Operating cash flow	9084286	Operating Cash Flow: 9084286 Open source
20222022-12-31	Operating cash flow	5221904	Operating Cash Flow: 5221904 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -11.9M 2022

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	15913413	Operating Cash Flow: 17107055 Open source Capital Expenditure: 1193642 Open source
20212021-12-31	Free cash flow	4773271	Operating Cash Flow: 9084286 Open source Capital Expenditure: 4311015 Open source
20222022-12-31	Free cash flow	-11890267	Operating Cash Flow: 5221904 Open source Capital Expenditure: 17112171 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

36.2% 2022

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Liabilities / assets	59.6%	Total Liabilities: 68840942 Open source Total Assets: 115489134 Open source
20212021-12-31	Liabilities / assets	32.5%	Total Liabilities: 56967400 Open source Total Assets: 175299877 Open source
20222022-12-31	Liabilities / assets	36.2%	Total Liabilities: 83152207 Open source Total Assets: 229804021 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.95× 2022

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	2.85×	Current Assets: 46728839 Open source Current Liabilities: 16421328 Open source
20212021-12-31	Current assets / current liabilities	3.93×	Current Assets: 101259423 Open source Current Liabilities: 25736917 Open source
20222022-12-31	Current assets / current liabilities	2.95×	Current Assets: 116620884 Open source Current Liabilities: 39561330 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 3.36 million Exact value Exact value: -3357746 USD 2020-01-01 – 2020-12-31: -3357746 USD Inspect Net Income Open source Share or cite Citation for Net Income · Thorne HealthTech, Inc. · 2020-12-31 Thorne HealthTech, Inc. (edgar:1844280) Net Income: -3357746 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -3357746 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017022003967/thrn-20211231.htm#4278827 Filing: 000095017022003967 The citation records this snapshot. The page link may show a newer release later.	USD 17.11 million Exact value Exact value: 17107055 USD 2020-01-01 – 2020-12-31: 17107055 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Thorne HealthTech, Inc. · 2020-12-31 Thorne HealthTech, Inc. (edgar:1844280) Operating Cash Flow: 17107055 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 17107055 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017022003967/thrn-20211231.htm#2415213 Filing: 000095017022003967 The citation records this snapshot. The page link may show a newer release later.	USD 1.19 million Exact value Exact value: 1193642 USD 2020-01-01 – 2020-12-31: 1193642 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Thorne HealthTech, Inc. · 2020-12-31 Thorne HealthTech, Inc. (edgar:1844280) Capital Expenditure: 1193642 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1193642 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017022003967/thrn-20211231.htm#2422326 Filing: 000095017022003967 The citation records this snapshot. The page link may show a newer release later.	USD 15.91 million Calculation and evidence 17107055 − 1193642 USD Exact free cash flow: 15913413 USD 2020-01-01 – 2020-12-31: 17107055 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 1193642 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Thorne HealthTech, Inc. · 2020-12-31 Thorne HealthTech, Inc. (edgar:1844280) Free cash flow: 15913413 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 17107055 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017022003967/thrn-20211231.htm#2415213 Filing: 000095017022003967 Input fundies:CapitalExpenditure: 1193642 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017022003967/thrn-20211231.htm#2422326 Filing: 000095017022003967 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	USD 7.25 million Exact value Exact value: 7253423 USD 2021-01-01 – 2021-12-31: 7253423 USD Inspect Net Income Open source Share or cite Citation for Net Income · Thorne HealthTech, Inc. · 2021-12-31 Thorne HealthTech, Inc. (edgar:1844280) Net Income: 7253423 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7253423 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#5200017 Filing: 000095017023011358 The citation records this snapshot. The page link may show a newer release later.	USD 9.08 million Exact value Exact value: 9084286 USD 2021-01-01 – 2021-12-31: 9084286 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Thorne HealthTech, Inc. · 2021-12-31 Thorne HealthTech, Inc. (edgar:1844280) Operating Cash Flow: 9084286 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9084286 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2843707 Filing: 000095017023011358 The citation records this snapshot. The page link may show a newer release later.	USD 4.31 million Exact value Exact value: 4311015 USD 2021-01-01 – 2021-12-31: 4311015 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Thorne HealthTech, Inc. · 2021-12-31 Thorne HealthTech, Inc. (edgar:1844280) Capital Expenditure: 4311015 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4311015 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2851613 Filing: 000095017023011358 The citation records this snapshot. The page link may show a newer release later.	USD 4.77 million Calculation and evidence 9084286 − 4311015 USD Exact free cash flow: 4773271 USD 2021-01-01 – 2021-12-31: 9084286 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 4311015 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Thorne HealthTech, Inc. · 2021-12-31 Thorne HealthTech, Inc. (edgar:1844280) Free cash flow: 4773271 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9084286 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2843707 Filing: 000095017023011358 Input fundies:CapitalExpenditure: 4311015 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2851613 Filing: 000095017023011358 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	USD 15.67 million Exact value Exact value: 15674040 USD 2022-01-01 – 2022-12-31: 15674040 USD Inspect Net Income Open source Share or cite Citation for Net Income · Thorne HealthTech, Inc. · 2022-12-31 Thorne HealthTech, Inc. (edgar:1844280) Net Income: 15674040 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 15674040 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#5198043 Filing: 000095017023011358 The citation records this snapshot. The page link may show a newer release later.	USD 5.22 million Exact value Exact value: 5221904 USD 2022-01-01 – 2022-12-31: 5221904 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Thorne HealthTech, Inc. · 2022-12-31 Thorne HealthTech, Inc. (edgar:1844280) Operating Cash Flow: 5221904 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 5221904 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2841657 Filing: 000095017023011358 The citation records this snapshot. The page link may show a newer release later.	USD 17.11 million Exact value Exact value: 17112171 USD 2022-01-01 – 2022-12-31: 17112171 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Thorne HealthTech, Inc. · 2022-12-31 Thorne HealthTech, Inc. (edgar:1844280) Capital Expenditure: 17112171 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17112171 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2849426 Filing: 000095017023011358 The citation records this snapshot. The page link may show a newer release later.	−USD 11.89 million Calculation and evidence 5221904 − 17112171 USD Exact free cash flow: -11890267 USD 2022-01-01 – 2022-12-31: 5221904 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 17112171 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Thorne HealthTech, Inc. · 2022-12-31 Thorne HealthTech, Inc. (edgar:1844280) Free cash flow: -11890267 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-04T10:33:52Z Snapshot: 3fd061e27d707d3f6e178d45539d5051097906d83d6a9dcbf72e3063372b7d7b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1844280?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 5221904 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2841657 Filing: 000095017023011358 Input fundies:CapitalExpenditure: 17112171 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1844280/000095017023011358/thrn-20221231.htm#2849426 Filing: 000095017023011358 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

9 filings · 880 latest values · 880 originally reported values

Dataset published 2026-11-04. Source filing dates and reporting periods are shown separately.

Identifiers: 0001844280, 1844280, THRN, edgar:1844280

Also known as THORNE HEALTHTECH, INC., Thorne HealthTech, Inc., Thorne Healthtech, Inc.

Thorne HealthTech, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2022 2022-01-01 – 2022-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation